Logo image of CHSCN

CHS INC - CHSINC 7.1 PERP (CHSCN) Stock Fundamental Analysis

NASDAQ:CHSCN - Nasdaq - US12542R5063 - Currency: USD

25.4  +0.03 (+0.12%)

Fundamental Rating

5

Overall CHSCN gets a fundamental rating of 5 out of 10. We evaluated CHSCN against 90 industry peers in the Food Products industry. CHSCN has an excellent profitability rating, but there are some minor concerns on its financial health. CHSCN does not seem to be growing, but still is valued expensively. CHSCN also has an excellent dividend rating. This makes CHSCN very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year CHSCN had a positive cash flow from operations.
In the past 5 years CHSCN has always been profitable.
CHSCN had a positive operating cash flow in each of the past 5 years.
CHSCN Yearly Net Income VS EBIT VS OCF VS FCFCHSCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

1.2 Ratios

With an excellent Return On Assets value of 7.92%, CHSCN belongs to the best of the industry, outperforming 84.44% of the companies in the same industry.
CHSCN has a better Return On Equity (14.11%) than 76.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.88%, CHSCN is in the better half of the industry, outperforming 62.22% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHSCN is below the industry average of 8.63%.
The last Return On Invested Capital (5.88%) for CHSCN is above the 3 year average (5.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROIC 5.88%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
CHSCN Yearly ROA, ROE, ROICCHSCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

With a decent Profit Margin value of 3.62%, CHSCN is doing good in the industry, outperforming 63.33% of the companies in the same industry.
CHSCN's Profit Margin has improved in the last couple of years.
CHSCN has a Operating Margin of 2.42%. This is comparable to the rest of the industry: CHSCN outperforms 44.44% of its industry peers.
CHSCN's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 5.06%, CHSCN is not doing good in the industry: 85.56% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CHSCN has grown nicely.
Industry RankSector Rank
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
CHSCN Yearly Profit, Operating, Gross MarginsCHSCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 1 2 3 4 5

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHSCN is still creating some value.
CHSCN has a better debt/assets ratio than last year.
CHSCN Yearly Shares OutstandingCHSCN Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCN Yearly Total Debt VS Total AssetsCHSCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

CHSCN has an Altman-Z score of 2.82. This is not the best score and indicates that CHSCN is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.82, CHSCN is doing good in the industry, outperforming 61.11% of the companies in the same industry.
CHSCN has a debt to FCF ratio of 1.02. This is a very positive value and a sign of high solvency as it would only need 1.02 years to pay back of all of its debts.
CHSCN's Debt to FCF ratio of 1.02 is amongst the best of the industry. CHSCN outperforms 88.89% of its industry peers.
CHSCN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
CHSCN has a better Debt to Equity ratio (0.19) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Altman-Z 2.82
ROIC/WACC1.02
WACC5.76%
CHSCN Yearly LT Debt VS Equity VS FCFCHSCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCN has a Current Ratio of 1.58. This is a normal value and indicates that CHSCN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.58, CHSCN perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
A Quick Ratio of 0.91 indicates that CHSCN may have some problems paying its short term obligations.
With a Quick ratio value of 0.91, CHSCN perfoms like the industry average, outperforming 51.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.91
CHSCN Yearly Current Assets VS Current LiabilitesCHSCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

1

3. Growth

3.1 Past

Looking at the last year, CHSCN shows a very negative growth in Revenue. The Revenue has decreased by -17.09% in the last year.
CHSCN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.88% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCN Yearly Revenue VS EstimatesCHSCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCN Price Earnings VS Forward Price EarningsCHSCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CHSCN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHSCN is cheaper than 97.78% of the companies in the same industry.
98.89% of the companies in the same industry are more expensive than CHSCN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.14
EV/EBITDA 0.96
CHSCN Per share dataCHSCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1K 2K 3K

4.3 Compensation for Growth

CHSCN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

8

5. Dividend

5.1 Amount

CHSCN has a Yearly Dividend Yield of 7.32%, which is a nice return.
Compared to an average industry Dividend Yield of 4.59, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 93.33% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, CHSCN pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.32%

5.2 History

CHSCN has paid a dividend for at least 10 years, which is a reliable track record.
CHSCN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
CHSCN Yearly Dividends per shareCHSCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CHSCN pays out 11.11% of its income as dividend. This is a sustainable payout ratio.
DP11.11%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCN Yearly Income VS Free CF VS DividendCHSCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B
CHSCN Dividend Payout.CHSCN Dividend Payout, showing the Payout Ratio.CHSCN Dividend Payout.PayoutRetained Earnings

More info and screens

CHS INC - CHSINC 7.1 PERP

NASDAQ:CHSCN (5/23/2025, 9:22:02 PM)

25.4

+0.03 (+0.12%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-01 2025-04-01
Earnings (Next)07-08 2025-07-08
Inst Owners13.41%
Inst Owner Change1120%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap311.66M
Analysts0
Price TargetN/A
Short Float %0.21%
Short Ratio1.28
Dividend
Industry RankSector Rank
Dividend Yield 7.32%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP11.11%
Div Incr Years0
Div Non Decr Years10
Ex-Date06-13 2025-06-13 (0.44375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.14
P/OCF 0.11
P/B 0.03
P/tB 0.03
EV/EBITDA 0.96
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)178.98
FCFY704.65%
OCF(TTM)233.94
OCFY921.01%
SpS3422.59
BVpS877.08
TBVpS877.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROCE 7.68%
ROIC 5.88%
ROICexc 6.17%
ROICexgc 6.17%
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
FCFM 5.23%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
ROICexc(3y)5.96%
ROICexc(5y)4.73%
ROICexgc(3y)6.08%
ROICexgc(5y)4.81%
ROCE(3y)7.21%
ROCE(5y)6.02%
ROICexcg growth 3Y73.02%
ROICexcg growth 5Y27.66%
ROICexc growth 3Y72.21%
ROICexc growth 5Y27.52%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
F-Score6
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Debt/EBITDA 1.33
Cap/Depr 122.19%
Cap/Sales 1.61%
Interest Coverage 250
Cash Conversion 182.9%
Profit Quality 144.65%
Current Ratio 1.58
Quick Ratio 0.91
Altman-Z 2.82
F-Score6
WACC5.76%
ROIC/WACC1.02
Cap/Depr(3y)76.68%
Cap/Depr(5y)79.95%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.13%
Profit Quality(3y)105.8%
Profit Quality(5y)111.96%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.39%
EBIT growth 3Y69.09%
EBIT growth 5Y26.62%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y620.74%
FCF growth 3Y59.62%
FCF growth 5Y30.48%
OCF growth 1Y387.5%
OCF growth 3Y44.56%
OCF growth 5Y25.04%